Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 5
1992 5
1993 2
1994 1
1995 3
1996 3
1997 4
1998 4
1999 12
2000 4
2001 6
2002 7
2003 3
2004 10
2005 1
2006 1
2007 1
2008 1
2009 2
2010 1
2011 6
2013 3
2014 3
2015 2
2016 2
2017 8
2018 3
2019 1
2020 5
2021 5
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

119 results
Results by year
Filters applied: . Clear all
Page 1
Glycosphingolipids and neuroinflammation in Parkinson's disease.
Belarbi K, Cuvelier E, Bonte MA, Desplanque M, Gressier B, Devos D, Chartier-Harlin MC. Belarbi K, et al. Among authors: chartier harlin mc. Mol Neurodegener. 2020 Oct 17;15(1):59. doi: 10.1186/s13024-020-00408-1. Mol Neurodegener. 2020. PMID: 33069254 Free PMC article. Review.
Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study.
Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A, Schulte C, Grover S, Mohamed O, Portugal B, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Duga S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Kawamura Y, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BPC, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Correia Guedes L, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Hellberg C, Clarke CE, Morrison KE, Tan M, Krainc D, Burbulla LF, Farrer MJ, Krüger R, Gasser T, Sharma M, Elbaz A; Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (Courage-PD) Consortium. Domenighetti C, et al. Among authors: chartier harlin mc. Mov Disord. 2022 Apr;37(4):857-864. doi: 10.1002/mds.28902. Epub 2022 Jan 8. Mov Disord. 2022. PMID: 34997937
LRRK2 Phosphorylation, More Than an Epiphenomenon.
Marchand A, Drouyer M, Sarchione A, Chartier-Harlin MC, Taymans JM. Marchand A, et al. Among authors: chartier harlin mc. Front Neurosci. 2020 Jun 16;14:527. doi: 10.3389/fnins.2020.00527. eCollection 2020. Front Neurosci. 2020. PMID: 32612495 Free PMC article. Review.
Alpha-Synuclein and Lipids: The Elephant in the Room?
Sarchione A, Marchand A, Taymans JM, Chartier-Harlin MC. Sarchione A, et al. Among authors: chartier harlin mc. Cells. 2021 Sep 17;10(9):2452. doi: 10.3390/cells10092452. Cells. 2021. PMID: 34572099 Free PMC article. Review.
ATXN2 a culprit with multiple facets.
Nkiliza A, Chartier-Harlin MC. Nkiliza A, et al. Among authors: chartier harlin mc. Oncotarget. 2017 May 23;8(21):34028-34029. doi: 10.18632/oncotarget.17112. Oncotarget. 2017. PMID: 28423350 Free PMC article. No abstract available.
Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease.
Domenighetti C, Sugier PE, Sreelatha AAK, Schulte C, Grover S, Mohamed O, Portugal B, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Duga S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Kawamura Y, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BP, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Guedes LC, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Hellberg C, Clarke CE, Morrison KE, Tan M, Krainc D, Burbulla LF, Farrer MJ, Krüger R, Gasser T, Sharma M, Elbaz A; Comprehensive Unbiaised Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease (Courage-PD) consortium. Domenighetti C, et al. Among authors: chartier harlin mc. J Parkinsons Dis. 2022;12(1):267-282. doi: 10.3233/JPD-212851. J Parkinsons Dis. 2022. PMID: 34633332 Free PMC article.
Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.
Moors TE, Hoozemans JJ, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin MC, van de Berg WD. Moors TE, et al. Among authors: chartier harlin mc. Mol Neurodegener. 2017 Jan 25;12(1):11. doi: 10.1186/s13024-017-0154-3. Mol Neurodegener. 2017. PMID: 28122627 Free PMC article. Review.
NADPH oxidases in Parkinson's disease: a systematic review.
Belarbi K, Cuvelier E, Destée A, Gressier B, Chartier-Harlin MC. Belarbi K, et al. Among authors: chartier harlin mc. Mol Neurodegener. 2017 Nov 13;12(1):84. doi: 10.1186/s13024-017-0225-5. Mol Neurodegener. 2017. PMID: 29132391 Free PMC article. Review.
[Parkinson disease: genetics and neuronal death].
Destée A, Mutez E, Kreisler A, Vanbesien-Maillot C, Chartier-Harlin MC. Destée A, et al. Among authors: chartier harlin mc. Rev Neurol (Paris). 2009 Apr;165 Spec No 2:F80-5. Rev Neurol (Paris). 2009. PMID: 19593875 Review. French. No abstract available.
119 results